Monitor the next quarterly report for any signs of operational disruption or financial reporting quality under the new interim CFO. The transition appears smooth, so no near-term trading catalyst from this change alone.
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Aug 17 $6.55entry
- T+1 · 3mo ago +6.87%α +7.55% · $7.00
- T+5 · 3mo ago +3.82%α +5.01% · $6.80
- T+20 · 2mo ago −13.28%α −11.30% · $5.68
- T+60 · 7d ago +17.25%α +20.20% · $7.68
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Profound Medical announced the resignation of CFO Rashed Dewan and the appointment of Corporate Controller Matthew Sobczyk as Interim CFO, effective August 14, 2026. The CFO departure is orderly with a transition consulting agreement, and the interim CFO is an internal promotion with deep company knowledge, making this a routine management change with no immediate financial impact on operations.
Key Facts
- CFO Rashed Dewan resigned effective August 14, 2026.
- Matthew Sobczyk, previously Corporate Controller, appointed Interim CFO effective same date.
- Dewan will serve as a consultant from August 17 to November 25, 2026, receiving CAD 200/hour + continued vesting of 20,000 RSUs.
- Dewan receives a $375,000 cash severance payment.
- Sobczyk's annual base salary set at CAD 300,414.58 with a 15% target bonus.
- No financial guidance, preliminary results, or revenue/earnings data were disclosed.
Financial Impact
CFO severance payment of $375,000; no impact on revenue, earnings, or operations disclosed.
Risk Factors
- Extended CFO vacancy could signal deeper organizational issues if a permanent replacement is not named within months.
- Loss of institutional knowledge if the consulting transition period is insufficient.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001171843-26-005575 |
| Exhibit: exh_991.htm | 0001171843-26-005575 |
| Document: 0001171843-26-005575-index-headers.html | 0001171843-26-005575 |
| Document: 0001171843-26-005575-index.html | 0001171843-26-005575 |
| Document: 0001171843-26-005575.txt | 0001171843-26-005575 |
Track record
22 reports on PROF
2 of 3 bullish or bearish reports moved the stock their way by T+20. Best: +25.61% at T+60 after the Mar 5, 2026 report. 3 of 4 went positive at some point.
Filters
- Nov 12, 20264d ago 8-K Neutral 3/10 Entry $7.44 Now $7.34 −1.34% settles Dec 11
- Nov 9, 20267d ago 8-K Neutral 2/10 Entry $7.34 Now $7.34 +0.00% settles Dec 8
- Nov 5, 202611d ago 8-K Bearish 5/10 Entry $7.21 Now $7.34 −1.80% settles Dec 7
- Nov 3, 202613d ago 8-K Neutral 4/10 Entry $7.16 Now $7.34 +2.51% settles Dec 3
- Oct 30, 202617d ago Press Release Neutral 4/10 Entry $6.57 Now $7.34 +11.72% settles Nov 30
- Oct 22, 202625d ago 8-K Neutral 2/10 Entry $5.56 Now $7.34 +32.01% settles Nov 20
- Oct 14, 20264w ago 8-K Neutral 3/10 Entry $6.62 to $7.68 Now $7.34 +10.88% ▲ +16.01% +18.57% vs SPY
- Oct 9, 20265w ago 8-K Neutral 3/10 Entry $6.90 to $7.01 Now $7.34 +6.38% ▲ +1.59% +7.15% vs SPY
- Oct 7, 20265w ago 8-K Bullish 7/10 Entry $6.91 to $7.16 Now $7.34 +6.22% ▲ +3.62% +8.91% vs SPY
- Sep 3, 202610w ago 8-K Neutral 2/10 Entry $6.89 to $6.03 Now $7.34 +6.53% ▼ −12.48% −13.08% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers